jte 522 has been researched along with thromboxane b2 in 1 studies
Studies (jte 522) | Trials (jte 522) | Recent Studies (post-2010) (jte 522) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
---|---|---|---|---|---|
61 | 1 | 7 | 7,483 | 715 | 485 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwamura, H; Matsushita, M; Tazaki, H; Wakitani, K | 1 |
1 other study(ies) available for jte 522 and thromboxane b2
Article | Year |
---|---|
JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
Topics: Animals; Benzenesulfonates; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Foot; Gastric Mucosa; Inflammation; Isoenzymes; Macrophages, Peritoneal; Male; Oxazoles; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 2000 |